Validation of Skeletal Muscle cis-Regulatory Module Predictions Reveals Nucleotide Composition Bias in Functional Enhancers
Figure 1
Selection of clones for differential expression analysis.
The selection is divided into 2 phases, where the clones selected for Phase 2 are a subset of all clones tested in Phase 1. Phase 1 and Phase 2 samples are from different plasmid preparations.